371. Between Policy and Justice: The Brazilian National Policy on Pharmaceuticals
- Author:
- Mariana Peixoto Socal
- Publication Date:
- 05-2010
- Content Type:
- Journal Article
- Journal:
- Woodrow Wilson School Journal of Public and International Affairs
- Institution:
- Woodrow Wilson School of Public and International Affairs, Princeton University
- Abstract:
- With around 190 million inhabitants, Brazil is one of the fastest growing pharmaceutical markets in the world. Annually, domestic pharmaceutical sales amount to approximately U.S. $15 billion and the country also imports an estimated U.S. $4 billion in pharmaceuticals (SINDUSFARMA 2010). The consumption of medicines is unequally distributed, with the richest 15 percent of the population consuming 48 percent, and the bottom 51 percent consuming only 16 percent (Dias 2006). To remedy this, the public healthcare system, Sistema Único de Saúde (SUS), provides medicines for free for those individuals who cannot afford them but have a medical prescription confirming their need. In 2007, SUS distributed more than 443 million free medicines throughout the country (DATASUS 2007).
- Political Geography:
- United States and Brazil